BIOMARKERS AND BOWEL URGENCY IN RESPONSE TO MIRIKIZUMAB FOR ULCERATIVE COLITIS
Marla C. Dubinsky 1
April Naegeli 2
Mingyang Shan 2
Cem Kayhan 2
Catherine Milch 2
Jochen Schmitz 2
Sylvie Bradesi 2
Simon Travis 3
1 Mount Sinai Hospital, Mount Sinai, New York City, United States
2 Eli Lilly and Company, Indianapolis, United States
3 Oxford University Hospitals, Oxford, United Kingdom
Session
IBD (Posters)
Conference
UEG Week Virtual 2021
Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]